At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2,195 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Naturalistic, Multisite, Observational Study of Rotigotine Transdermal Patch and Other Currently Prescribed Therapies in Patients With Idiopathic Parkinson's Disease
In Brief
An observational study for Idiopathic Parkinson Disease. Completed, enrolled 2,195 participants across 211 sites in 10 countries.
Detailed Summary
This study will be conducted in an observational multiple-cohort design aimed at acquiring clinical, treatment, health status, and economic data. Patients with Parkinson's disease (PD) will be enrolled.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsIdiopathic Parkinson Disease
CountriesCzechia, Denmark, Germany, Greece, Italy, Mexico, Romania, Slovakia, Spain, Switzerland
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2006
First PostedJan 2008
Primary CompletionApr 2014
TodayJul 2026
First PostedJan 23, 2008
Enrollment StartJun 1, 2006
Primary CompletionApr 1, 2014
TodayJul 2, 2026
Enrollment to primary: 7.8 yearsPosted 18.4 years ago